Browse by Aston Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Date | No Grouping
Jump to: Article | Thesis
Number of items: 41.

Article

Bailey, Clifford J (2019). FDA guidance on cardiovascular risk of antidiabetic therapies: one decade later. Diabetes, Obesity and Metabolism ,

Bailey, Clifford J (2019). Uric acid and the cardio-renal effects of SGLT2 inhibitors. Diabetes, Obesity and Metabolism ,

Bailey, Clifford J. and Marx, Nikolaus (2018). Cardiovascular protection in type 2 diabetes:Insights from recent outcome trials. Diabetes, Obesity and Metabolism ,

Bailey, Clifford J (2018). European Medicines Agency: approval of new glucose-lowering medicines for type 2 diabetes. Diabetes, Obesity and Metabolism, 20 (9), pp. 2057-2058.

Bailey, Clifford J and Day, Caroline (2018). Treatment of type 2 diabetes: future approaches. British Medical Bulletin, 126 (1), pp. 123-137.

Bailey, Clifford J. (2018). Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides. Peptides, 100 , pp. 9-17.

Rana, Karan S, Pararasa, Chathyan, Afzal, Islam, Nagel, David A, Hill, Eric J, Bailey, Clifford J, Griffiths, Helen R, Kyrou, Ioannis, Randeva, Harpal S, Bellary, Srikanth and Brown, James E (2017). Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels. Cardiovascular Diabetology, 16 (1),

Lascar, Nadia, Brown, James, Pattison, Helen, Barnett, Anthony H., Bailey, Clifford J. and Bellary, Srikanth (2017). Type 2 diabetes in adolescents and young adults. The Lancet Diabetes and Endocrinology, in pre ,

Aggarwal, Naresh, Singla, Anuj, Mathieu, Chantal, Montanya, Eduard, Pfeiffer, Andreas F.H., Johnsson, Eva, Zhao, June, Iqbal, Nayyar and Bailey, Clifford (2017). Metformin extended-release versus immediate-release:An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetes. Diabetes, Obesity and Metabolism, Early ,

Bailey, Clifford J. (2017). Metformin:historical overview. Diabetologia, 60 (9), 1566–1576.

Blonde, Lawrence, Aschner, Pablo, Bailey, Clifford, Ji, Linong, Leiter, Lawrence A., Matthaei, Stephan and on behalf of the Global Partnership for Effective Diabetes Manag (2017). Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diabetes and Vascular Disease Research, 14 (3), pp. 172-183.

McGill, Margaret, Blonde, Lawrence, Chan, Juliana C.N., Khunti, Kamlesh, Lavalle, Fernando J. and Bailey, Clifford J. (2017). The interdisciplinary team in type 2 diabetes management:challenges and best practice solutions from real-world scenarios. Journal of Clinical and Translational Endocrinology, 7 , pp. 21-27.

Tahrani, Abd A., Barnett, Anthony H. and Bailey, Clifford J. (2016). Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature Reviews Endocrinology, 12 (10), 566–592.

Wilding, John, Bailey, Clifford, Rigney, Una, Blak, Betina, Beekman, Wendy and Emmas, Cathy (2016). Glycated hemoglobin, body weight and blood pressure in type 2 diabetes patients initiating dapagliflozin treatment in primary care:a retrospective study. Diabetes Therapy, 7 (4), pp. 695-711.

McCreight, Laura J., Bailey, Clifford J. and Pearson, Ewan R. (2016). Metformin and the gastrointestinal tract. Diabetologia, 59 (3), pp. 426-435.

Pararasa, Chathyan, Ikwuobe, John, Shigdar, Shahjahan, Boukouvalas, Alexis, Nabney, Ian T., Brown, James E., Devitt, Andrew, Bailey, Clifford J., Bennett, Stuart J. and Griffiths, Helen R. (2016). Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell, 15 (1), pp. 128-139.

Bailey, Clifford J., Tahrani, Abd A. and Barnett, Anthony H. (2016). Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes and Endocrinology, 4 (4), pp. 350-359.

Pararasa, Chathyan, Bailey, Clifford J. and Griffiths, Helen R. (2015). Ageing, adipose tissue, fatty acids and inflammation. Biogerontology, 16 (2), pp. 235-248.

Inzucchi, Silvio E., Lipska, Kasia J., Mayo, Helen, Bailey, Clifford J. and McGuire, Darren K. (2014). Metformin in patients with type 2 diabetes and kidney disease:a systematic review. JAMA: Journal of the American Medical Association, 312 (24), pp. 2668-2675.

Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc and Raz, Itamar (2014). Insulin therapy in people with type 2 diabetes:opportunities and challenges? Diabetes Care, 37 (6), pp. 1499-1508.

Rana, Karan S., Arif, Muhammad, Hill, Eric J., Aldred, Sarah, Nagel, David A., Nevill, Alan, Randeva, Harpal S., Bailey, Clifford J., Bellary, Srikanth and Brown, James E. (2014). Plasma irisin levels predict telomere length in healthy adults. Age, 36 (2), pp. 995-1001.

Al-Khattawi, Ali, Iyire, Affiong, Dennison, Tom, Dahmash, Eman, Bailey, Clifford J, Smith, Julian, Rue, Peter and Mohammed, Afzal R. (2014). Systematic screening of compressed ODT excipients : cellulosic versus non-cellulosic. Current drug delivery, 11 , pp. 1-15.

Iyrie, Affiong, Russell, Craig, Bailey, Clifford J and Mohammed, Afzal (2014). Investigating buccal cell cultures to enhance in vitro assessment of transmucosal drug delivery. UKICRS Newsletter , pp. 38-40.

Bailey, Clifford J. (2013). Interpreting adverse signals in diabetes drug development programs. Diabetes Care, 36 (7), pp. 2098-2106.

Fouqueray, Pascale, Pirags, Valdis, Inzucchi, Silvio E., Bailey, Clifford J., Schernthaner, Guntram, Diamant, Michaela and Lebovitz, Harold E. (2013). The efficacy and safety of imeglimin as add-on therapy in patientswith type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care, 36 (3), pp. 565-568.

Bailey, Clifford J., Gross, Jorge L., Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A. and List, James F. (2013). Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin:a randomized, double-blind, placebo-controlled 102-week trial. BMC Medicine, 11 (1),

Gao, Dan, Pararasa, Chathyan, Dunston, Christopher R, Bailey, Clifford J. and Griffiths, Helen R. (2012). Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. Free Radical Biology and Medicine, 53 (4), 796–806.

Bailey, Clifford J. (2011). The challenge of managing coexistent type 2 diabetes and obesity. BMJ, 342 (7803),

Lipska, Kasia J, Bailey, Clifford J and Inzucchi, Silvio E (2011). Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care, 34 (6), pp. 1431-1437.

Del Prato, Stefano, LaSalle, J., Matthaei, S., Bailey, Clifford and Global Partnership for Effective Diabetes Management (2010). Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. International Journal of Clinical Practice, 64 (3), pp. 295-304.

Kerr, Barry D, Irwin, Nigel, O'Harte, Finbarr P M, Bailey, Clifford J, Flatt, Peter R and Gault, Victor A (2009). Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Biochemical Pharmacology, 78 (8), pp. 1008-1016.

Bailey, Cliff J. (2008). Metformin:a multitasking medication. Diabetes and Vascular Disease Research, 5 (3), p. 156.

Home, P.D., Bailey, C.J., Donaldson, J., Chen, H. and Stewart, M.W. (2007). A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with type 2 diabetes. Diabetic Medicine, 24 (6), pp. 618-625.

Richardson, D.K., Jones, R.B. and Bailey, C.J. (2006). The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes. Hormone and Metabolic Research, 38 (11), pp. 727-731.

Irwin, Nigel, Green, Brian D., Gault, Victor A., Greer, Brett, Harriott, Patrick, Bailey, Clifford J., Flatt, Peter R. and O'Harte, Finbarr P.M. (2005). Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide. Journal of Medicinal Chemistry, 48 (4), pp. 1244-1250.

Bailey, C.J and Day, C. (2004). Avandamet:Combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. International Journal of Clinical Practice, 58 (9), pp. 867-876.

Bailey, C.J. and Turner, S.L. (2004). Glucosamine-induced insulin resistance in L6 muscle cells. Diabetes, Obesity and Metabolism, 6 (4), pp. 293-298.

Green, B.D., Mooney, M.H., Gault, V.A., Irwin, N., Bailey, C.J., Harriott, P., Greer, B., O'Harte, F.P.M. and Flatt, P.R. (2004). N-terminal His7-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. Journal of Endocrinology, 180 (3), pp. 379-388.

Green, B.D., Gault, V.A., Mooney, M.H., Irwin, N., Harriott, P., Greer, B., Bailey, C.J., O'Harte, F.P.M. and Flatt, P.R. (2004). Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues. Biological Chemistry, 385 (2), pp. 169-177.

Green, B.D., Gault, V.A., Mooney, M.H., Irwin, N., Bailey, C.J., Harriott, P., Greer, B., Flatt, P.R. and O'Harte, F.P.M. (2003). Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. Journal of Molecular Endocrinology, 31 (3), pp. 529-540.

Thesis

Bailey, Clifford J. (1973). Studies on the influence of sex hormones on glucose tolerance and insulin secretion in the rat. PHD thesis, Aston University.

This list was generated on Thu Mar 21 00:55:22 2019 GMT.